Stroke News

Non-vitamin K antagonist oral anticoagulants conferred lower risk for ischemic stroke and major bleeding in patients with atrial fibrillation and a history of gastrointestinal bleeding compared with warfarin, according to study results.

Immediate insertion of a cardiac monitor following first cryptogenic stroke was cost-effective in the U.S. compared with delayed implantation after 30-day Holter monitoring, according to a study.

There has been much discussion about patient-centered outcomes in CVD therapy and treatment, but little consensus exists as to their definition and value.

In a national private health care database, age, male sex and comorbidities increased risk for death in patients hospitalized with COVID-19, according to data presented at the virtual American Heart Association Scientific Sessions.

Regular intake of glucosamine/chondroitin was associated with lower all-cause and CVD mortality among adults aged older than 40 years in the United States, data from a cohort study showed.

The FDA has classified Cook Medical’s recall of two catheters used in vascular procedures as Class I, the most serious type.

Neurological syndromes on admission in patients with COVID-19, including altered mentation and stroke, predicted greater mortality risk in a large, single-center study in New York City, according to findings published in Neurology.

The FDA announced that in response to its request, Penumbra has issued an urgent recall of reperfusion catheters for clot removal in patients with stroke due to risk for unexpected death or serious injury.

Among pregnant and postpartum women, Black women remained at increased risk for mortality and stroke compared with white women despite trends for improved CV outcomes, researchers reported.

Baseline depressive symptoms appeared modestly associated with cardiovascular disease incidence, including at symptoms levels below a typical depressive disorder threshold, according to study results published in JAMA.